(Q40433315)

20 September 2017

1 reference

title

Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides (English)

1 reference

20 September 2017

Liposomes as Carriers of Peptide Antigens: Induction of Antibodies and Cytotoxic T Lymphocytes to Conjugated and Unconjugated Peptides (English)

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

30 May 2024

0 references

0 references

1 reference

C. R. Alving

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590830

30 May 2024

V. Koulchin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590830

30 May 2024

G. M. Glenn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590830

30 May 2024

M. Rao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590830

30 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7590830

30 May 2024

publication date

1 June 1995

1 reference

full work available at URL

20 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-065X.1995.tb00075.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1600-065X.1995.tb00075.x

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

30 May 2024

published in

Immunological Reviews

1 reference

20 September 2017

volume

145

1 reference

20 September 2017

page(s)

5-31

1 reference

Delivery of liposome-encapsulated drugs to macrophages

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Liposomes as carriers of antigens and adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Liposomes containing lipid A: a potent nontoxic adjuvant for a human malaria sporozoite vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Effectiveness of liposomes as potential carriers of vaccines: applications to cholera toxin and human malaria sporozoite antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Immunopotentiating reconstituted influenza virosomes (IRIVs) and other adjuvants for improved presentation of small antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Adjuvants--a balance between toxicity and adjuvanticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Carrier-priming leads to hapten-specific suppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Impediments, imponderables and alternatives in the attempt to develop an effective vaccine against AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

A single vaccination with an inactivated hepatitis A liposome vaccine induces protective antibodies after only two weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Phase 1 clinical tests of influenza MDP-virosome vaccine (KD-5382).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Development of a vaccine for the prevention of AIDS, a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Current concepts in membrane protein reconstitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Production of antibodies against murine class II antigens using unconjugated synthetic peptides of the beta chain region 63-78.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Introduction of soluble protein into the class I pathway of antigen processing and presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Immunogenicity of liposomal malaria sporozoite antigen in monkeys: adjuvant effects of aluminium hydroxide and non-pyrogenic liposomal lipid A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Conformational restriction of peptidyl immunogens with covalent replacements for the hydrogen bond

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Vaccine delivery systems: potential methods for use in antifertility vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Phagocytosis of liposomes by macrophages: intracellular fate of liposomal malaria antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Production and use of antibodies against synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Liposomes as carriers for vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Induction of cytolytic and antibody responses using Plasmodium falciparum repeatless circumsporozoite protein encapsulated in liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Synthetic peptides as antigens: pitfalls of conjugation methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Effects of Lipid A on the Immunologic Properties of Liposomal Model Membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Production of Monoclonal Antibodies to Surface Regions that are Non-Immunogenic in a Protein Using Free Synthetic Peptide as Immunogens: Demonstration with Sperm-Whale Myoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Characterization and kinetics of MHC class I-restricted presentation of a soluble antigen delivered by liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00075.X

Novel adjuvant strategies for experimental malaria and AIDS vaccines

21 January 2018

8

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparum

30 May 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

Intrinsic and extrinsic factors in protein antigenic structure

30 May 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

Development of artificial vaccines against HIV using defined epitopes

30 May 2024

14

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

Influence of peptide acylation, liposome incorporation, and synthetic immunomodulators on the immunogenicity of a 1-23 peptide of glycoprotein D of herpes simplex virus: implications for subunit vaccines

30 May 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

Structure of the Gene Encoding the Immunodominant Surface Antigen on the Sporozoite of the Human Malaria Parasite Plasmodium falciparum

30 May 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

Mechanisms of Neutralization of Animal Viruses

30 May 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

An update on vaccine adjuvants in clinical trial

30 May 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

30 May 2024

Adjuvants

22

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

How cells process antigens.

30 May 2024

23

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy

30 May 2024

25

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid

30 May 2024

26

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein

30 May 2024

27

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

Murine IgG subclass antibodies to antigens incorporated in liposomes containing lipid A.

30 May 2024

28

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A

30 May 2024

30

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells

30 May 2024

31

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

Influence of Antigens on Release of Free Fatty Acids from Arlacel A (Mannide Monooleate)

30 May 2024

33

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

Critical appraisal of emulsified oil adjuvants applied to viral vaccines

30 May 2024

35

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles

30 May 2024

42

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

Tumor eradication by adoptive transfer of cytotoxic T lymphocytes

30 May 2024

48

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

Mineral oil adjuvants: biological and chemical studies

30 May 2024

51

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

Antibodies to Hepatitis B Surface Antigen (HBsAg) Elicited by Immunization with a Synthetic Peptide Covalently Linked to Liposomes

30 May 2024

52

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

Immunogenicity and toxicity testing of an experimental HIV-1 vaccine in nonhuman primates

30 May 2024

53

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

A strategy for making synthetic peptide vaccines

30 May 2024

54

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

Studies on the Topography of the Catalytic Site of Acetylcholinesterase Using Polyclonal and Monoclonal Antibodies

30 May 2024

55

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

Antiviral cytotoxic T lymphocyte induction and vaccination

30 May 2024

65

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

Structural requirements of lipid A for endotoxicity and other biological activities

30 May 2024

71

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

The basis for the immunoregulatory role of macrophages and other accessory cells

30 May 2024

73

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

New scientific opportunities and old obstacles in vaccine development

30 May 2024

80

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

Antibody and cytotoxic T-lymphocyte responses to a single liposome-associated peptide antigen

30 May 2024

83

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine

30 May 2024

88

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00075.X

30 May 2024

Identifiers

1 reference

20 September 2017

1 reference